MAP4K4 and neoplasm: Augmented dipeptides induce the expression of MAP4K4 and promote the phosphorylation of G3BP2 at Thr227, leading to the activation of epithelial‐mesenchymal transition (EMT) signaling, which facilitates the metastasis of tumor cells.